Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

KERN Stock: What Happened, and What’s Next

Akerna (KERN) caused quite a bit of excitement in the pot stock community last week. Its meteoric rise might have looked magical – or like a fluke. But, in fact, KERN stock’s success has been a long time coming.

Best Stocks for 2019: Amazon Primed for Profits

In a tight Best Stocks for 2019 race, readers' choice AMZN stock is holding onto third place. But with Prime Day coming up and one-day shipping rolling out, increased revenue is on the way in Q3.

Should You Buy Advanced Micro Devices Stock? 3 Things to Consider

Should you buy AMD stock? Advanced Micro Devices sports a number of strong tailwinds that make it a long-term buying opportunity.

JD Stock Is the Best Chinese Equity

With a change in investors’ attitudes, JD stock, which is currently very undervalued, has a chance to gain some momentum.

Is Microsoft a $100 Stock or a $200 Stock?

Microsoft hit an all-time high of $138.40 on June 24. Can $200 be too far away for MSFT stock? The article examines that question.

Amazon Is the Ultimate Startup — Stay Long to $2,100 and Beyond

Amazon stock is the ultimate startup that is highly profitable. If the S&P 500 is higher down the line, then AMZN is leading it.

Why Electronic Arts Stock Looks Poised to Reach $110 in 2019

EA looks ready to shake off its recent operational weakness, enabling EA stock to rally over the next several months

CVS Stock Is Cheap for a Reason

CVS stock trades at a low multiple, and this will likely remain the case until management can restore confidence in CVS Health stock.

Selling Beauty Products Won’t Help Amazon Stock, but It Will Hurt SBH

According to DA Davidson analysts, Amazon’s entry will directly affect 19% of Sally Beauty’s operating profit while an additional 33% could be under duress to the increased competition. 

Is the Growth Story for Nvidia Stock Still Intact?

NVDA stock looks ready to rocket in the second half of the year as long as Nvidia management's rhetoric regarding its recovery is true.

Why 3M Stock May Be a Buy on This Big Dip

An overvalued, slow-growth narrative has transitioned into an underappreciated play for embattled 3M stock.

GE Stock Still Is a Dicey Proposition, but It Looks Better Every Day

GE stock has performed well so far in 2019, but can it work its way back toward previous highs?

AMD Stock Is Still a Good Buy as It Begins Leveling Off

AMD CEO Dr. Lisa Su is now hailed as one of the world's great CEOs, after leading AMD and its Ryzen architecture to glory against Intel. But the company remains a minnow in the semiconductor space

Repeated Failures Are A Big Part Of The Bull Case For Amazon Stock

Amazon has failed more often than it's succeeded. That's the point.

Can Nvidia Stock March Back to $200? 

Can Nvidia stock make its way back to $200 per share? Perhaps, but we need to see NVDA clear some of these headwinds first.

How to Get Past the “Hard Right Edge” And Find Breakthrough Stocks to Buy

The vertical line on the right side of a stock chart represents uncharted territory...the uncertain future...where the trader picking stocks to buy can only speculate as to their success (or failure). I’ll show you one of the ultimate ways to stack the odds in your favor and succeed after crossing that hard right edge.

3 Biopharma Stocks to Buy for Income

These biopharma stocks could be perfect stocks to buy for those looking at the long term or for anyone looking for strong dividend stocks.

7 Stocks That Insiders Are Buying

Insider buying could be a great bullish indicator for a stock. Insiders sell for many reason, but they only buy for one -- and maybe you should buy too.

Target’s Near-Term Struggles Won’t Knock it off Course

Despite near-term issues at TGT, the fundamentals supporting Target stock remain as healthy as they have been at any point over the past decade.